BMO Capital analyst Simeon Siegel maintains Bath & Body Works (NYSE:BBWI) with a Outperform and raises the price target from $45 to $48.
Rubicon Organics FY22 Revenue Grows 57% To $26.4M, What About Adjusted EBITDA?
Rubicon Organics Inc. (OTCQX: ROMJF) (TSXV:ROMJ) achieved a record net revenue in FY 2022 of CA$35.5 million ($26.4 million), a 57% increase compared t